Ubs Group Ag Evotec Se Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Evotec Se stock. As of the latest transaction made, Ubs Group Ag holds 10,360 shares of EVO stock, worth $40,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,360
Previous 13,620
23.94%
Holding current value
$40,093
Previous $45,000
4.44%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding EVO
# of Institutions
37Shares Held
3.79MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA1.21MShares$4.67 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT1.11MShares$4.31 Million2.33% of portfolio
-
Morgan Stanley New York, NY385KShares$1.49 Million0.0% of portfolio
-
Wcm Investment Management, LLC Laguna Beach, CA298KShares$1.15 Million0.0% of portfolio
-
Pitcairn CO Jenkintown, PA261KShares$1.01 Million0.07% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.37B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...